Cosmos HealthCOSM -10.91%29 Days Payable is 78.76 as of Mar. 2026, which is 0% below its 10-year median of 79.04. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, Cosmos Health ranks worse than 50.43% on this metric.
The historical rank and industry rank for Cosmos Health's Days Payable or its related term are showing as below:
COSM'
s Days Payable Range Over the Past 10 Years
Min: 15.32 Med: 79.04 Max: 91.81
Current: 79.11
During the past 13 years, Cosmos Health's highest Days Payable was 91.81. The lowest was 15.32. And the median was 79.04.
COSM's Days Payable is ranked worse than 50.43% of 117
companies
in the Medical Distribution industry
Industry Median: 79.11
vs COSM: 79.11
Cosmos Health's Days Payable
declined
from Mar. 2025 (89.31) to Mar. 2026 (78.76).
It may suggest that Cosmos Healthaccelerated paying its suppliers.
Cosmos Health Days Payable Related Terms
Cosmos Health Days Payable Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cosmos Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cosmos Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a Days Payable of 78.76 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cosmos Health and its competitors. This is near median its historical median of 79.04. Over the past decade, Cosmos Health's Days Payable has ranged from 15.32 to 91.81. According to the industry distribution chart, Cosmos Health ranks #59 out of 117 companies in the Medical Distribution industry, placing it in the top 50.4%.
Is Cosmos Health's Days Payable too high?
Cosmos Health's current Days Payable of 78.76 is near median its 10-year median of 79.04. Over the past 10 years, this metric has ranged from a low of 15.32 to a high of 91.81. The Medical Distribution industry median Days Payable is 79.11. Cosmos Health's value of 78.76 is 0.4% below this industry median. Based on the distribution chart, Cosmos Health ranks #59 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Days Payable compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #59 out of 117 companies for Days Payable. This places Cosmos Health in the lower half of its industry. The industry median Days Payable is 79.11. Cosmos Health's value of 78.76 is 0.4% below this benchmark. Historically, Cosmos Health's own Days Payable has ranged from 15.32 to 91.81 over the past decade. While the company's 10-year median is 79.04 vs. the industry median of 79.11, Cosmos Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current Days Payable of 78.76 is 0.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Days Payable is 78.76, which is near median its own 10-year median of 79.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.19 — trading 48.5% below its estimated fair value. The current Days Payable is 78.76, which is near median its 10-year median of 79.04 and 0.4% below the Medical Distribution industry median of 79.11. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cosmos Health (COSM), the current Days Payable is 78.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.19 is trading 48.5% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Days Payable: 78.76 (near median its 10-year median of 79.04)
GF Value™: $0.36 vs. price of $0.19 (48.5% below fair value)
Industry Position: 0.4% below the Medical Distribution median (#59 of 117)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
